ReviewTheranostics2022
Glucose biosensors in clinical practice: principles, limits and perspectives of currently used devices.
Review in Theranostics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
54 citing papers in PubMed, 1 synthesis or guideline pooled it, 177 citations in OpenAlex.
- A Concise and Systematic Review on Non-Invasive Glucose Monitoring for Potential Diabetes Management.Biosensors · 2022Pooled it
- Review
- Reservoir Computing-Based Glucose Sensing With an Enzymatic Reaction Network.Angewandte Chemie (International ed. in English) · 2026Article
- Hypotony-Free Closure of Infusion Sclerotomy Using a Slit-Modified Trocar in 23-Gauge Vitrectomy for Proliferative Diabetic Retinopathy.Bioengineering (Basel, Switzerland) · 2026Article
- Recent Advances in Glucose Biosensors.Biosensors · 2026Article
- Glucose oxidase-powered nanocatalytic medicine: Rewiring tumor metabolism for multimodal cancer therapy.Materials today. Bio · 2026Review
- [Study of accuracy assessment of the Gmate LIFE blood glucose monitoring system].Problemy endokrinologii · 2026Article
- Smart biomaterials for cardiovascular, bone, and skin tissue engineering: mechanisms, applications, and future prospects.Journal of biological engineering · 2026Review
- Body Biofluids for Minimally-Invasive Diagnostics: Insights, Challenges, Emerging Technologies, and Clinical Potential.Advanced healthcare materials · 2026Review
- Nanostructure driven innovation in diabetes: from enhanced biosensing to smart therapeutic delivery.Frontiers in bioengineering and biotechnology · 2026Review
- A ZIF-8-Based High-Performance Glucose Electrochemical Detection Platform Constructed Using a Multi-Layer Interface Optimization Strategy.Sensors (Basel, Switzerland) · 2025Article
- The Convergence of Polymer Science and Predictive Modeling for Noninvasive Glucose Monitoring.Pharmaceutics · 2025Review
- Cancer and Aging Biomarkers: Classification, Early Detection Technologies and Emerging Research Trends.Biosensors · 2025Review
- Electrochemical and Nanomaterial-Based Strategies for Nonenzymatic Glucose Detection: A Review.ChemistryOpen · 2025Review
- A Review of Graphene-Integrated Biosensors for Non-Invasive Biochemical Monitoring in Health Applications.Sensors (Basel, Switzerland) · 2025Review
- Glucose Oxidase Initiates Radical Polymerizations by Direct Electron Transfer to Monomers.Biomacromolecules · 2025Article
- Nanostructured Materials in Glucose Biosensing: From Fundamentals to Smart Healthcare Applications.Biosensors · 2025Review
- Design of a Wearable Finger PPG-Based Blood Glucose Monitor.Annals of biomedical engineering · 2025Article
- Analysis of Adverse Events in Medical Devices for Diabetes.Journal of diabetes science and technology · 2025Article
- A universal oxygen scavenger for oxidase-based biosensors.Science advances · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The demand of glucose monitoring devices and even of updated guidelines for the management of diabetic patients is dramatically increasing due to the progressive rise in the prevalence of diabetes mellitus and the need to prevent its complications. Even though the introduction of the first glucose sensor occurred decades ago, important advances both from the technological and clinical point of view have contributed to a substantial improvement in quality healthcare. This review aims to bring together purely technological and clinical aspects of interest in the field of glucose devices by proposing a roadmap in glucose monitoring and management of patients with diabetes. Also, it prospects other biological fluids to be examined as further options in diabetes care, and suggests, throughout the technology innovation process, future directions to improve the follow-up, treatment, and clinical outcomes of patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.